Venrock Adviser, LLC
33 holdingsFiling period: 2026-06-30Current AUM: $3.01Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | APGE | Apogee Therapeutics Inc | 8.49M | $1.13B | $1.13B | 37.42% | -- | 2026-06-30 |
| 2 | ORKA | Oruka Therapeutics Inc | 4.15M | $394.8M | $328.1M | 10.89% | -- | 2026-06-30 |
| 3 | ERAS | Erasca Inc | 17.89M | $327.8M | $261.6M | 8.68% | +1.51M | 2026-06-30 |
| 4 | SYRE | Spyre Therapeutics Inc | 2.99M | $265.0M | $272.9M | 9.06% | -700,000 | 2026-06-30 |
| 5 | DNTH | Dianthus Therapeutics Inc | 1.18M | $115.0M | $92.9M | 3.08% | -- | 2026-06-30 |
| 6 | OCUL | Ocular Therapeutix Inc | 10.35M | $101.6M | $68.8M | 2.28% | -- | 2026-06-30 |
| 7 | DMRA | Damora Therapeutics Inc | 3.60M | $93.7M | $74.5M | 2.47% | -- | 2026-06-30 |
| 8 | SVRA | Savara Inc | 14.75M | $90.8M | $70.2M | 2.33% | +1.01M | 2026-06-30 |
| 9 | JBIO | Jade Biosciences Inc | 3.22M | $71.6M | $47.9M | 1.59% | -- | 2026-06-30 |
| 10 | COGT | Cogent Biosciences Inc | 1.64M | $63.6M | $51.3M | 1.70% | -357,834 | 2026-06-30 |
| 11 | VRDN | Viridian Therapeutics Inc | 3.26M | $59.8M | $73.1M | 2.43% | -624,792 | 2026-06-30 |
| 12 | VOR | Vor Biopharma Inc | 3.04M | $56.0M | $57.9M | 1.92% | -- | 2026-06-30 |
| 13 | DYN | Dyne Therapeutics Inc | 2.17M | $48.3M | $35.4M | 1.17% | -- | 2026-06-30 |
| 14 | MAZE | Maze Therapeutics Inc | 1.60M | $47.8M | $52.0M | 1.73% | -- | 2026-06-30 |
| 15 | RLMD | Relmada Therapeutics Inc | 6.84M | $47.4M | $23.0M | 0.76% | +2.00M | 2026-06-30 |
| 16 | ORIC | Oric Pharmaceuticals Inc | 4.32M | $46.8M | $59.5M | 1.98% | -- | 2026-06-30 |
| 17 | — | Crescent Biopharma Inc. | 2.13M | $38.4M | $38.4M | 1.27% | -- | 2026-06-30 |
| 18 | — | Zura Bio Ltd | 6.43M | $38.0M | $38.0M | 1.26% | -- | 2026-06-30 |
| 19 | ANL | Adlai Nortye Ltd | 3.21M | $36.9M | $34.2M | 1.13% | -- | 2026-06-30 |
| 20 | ELVN | Enliven Therapeutics Inc | 526.3K | $26.7M | $21.7M | 0.72% | -1,200,000 | 2026-06-30 |
| 21 | HELP | Cybin Inc | 3.85M | $25.5M | $42.1M | 1.40% | -- | 2026-06-30 |
| 22 | CGEM | Cullinan Therapeutics Inc | 1.38M | $25.1M | $20.5M | 0.68% | -- | 2026-06-30 |
| 23 | IPSC | Century Therapeutics Inc | 8.70M | $21.3M | $14.3M | 0.47% | -- | 2026-06-30 |
| 24 | ARTV | Artiva Biotherapeutics Inc | 2.04M | $19.8M | $13.4M | 0.44% | +434.0K | 2026-06-30 |
| 25 | CTMX | Cytomx Therapeutics Inc | 4.98M | $18.7M | $12.5M | 0.42% | -5,000,000 | 2026-06-30 |
← Scroll →
Page 1 of 2